Home Tools
Log in
Cart
Proteases/Proteasome DPP-4

DPP-4

Cat No. product name
T7369L Gemigliptin Tartrate(911637-19-9 free base) Gemigliptin tartrate is a highly selective, reversible and competitive inhibitor of dipeptidyl peptidase-4 (DPP-4). It has an IC50 of 10.3 nM for human recombi...
T2401 Alogliptin Benzoate Alogliptin Benzoate(SYR 322), an effective and specific DPP-4 inhibitor (IC50<10 nM), exhibits greater than 10, 000-fold selectivity over DPP-8/9. Alogliptin may...
T2316 Omarigliptin Omarigliptin has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Chronic Renal Insufficiency.
T1502 Vildagliptin Vildagliptin is a cyanopyrrolidine-based, orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Vildagliptin's cyano moiet...
T6203 Saxagliptin Saxagliptin is a selective and reversible DPP4 inhibitor with IC50 of 26 nM.
T1581 Picolamine Picolamine acts as a potential inhibitor of DPP-4.
T0242 Sitagliptin Sitagliptin, a new oral hypoglycemic (anti-diabetic drug), is a new dipeptidyl peptidase-4 (DPP-4) inhibitor. This enzyme-inhibiting drug is used either alone or...
T1366 3-Pyridylacetic acid hydrochloride 3-Pyridylacetic acid hydrochloride is an organic compund.
T0191 Linagliptin Linagliptin is a potent, orally bioavailable dihydropurinedione-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity.
T6192 Alogliptin Alogliptin(SYR-322) is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10, 000-fold selectivity over DPP-8 and DPP-9.
T6237 Trelagliptin Trelagliptin is a highly specific and long-acting DPP-4 inhibitor.
T16838 Saikogenin A Saikogenin A is a dipeptidyl peptidase-4 inhibitor.
T6999 Teneligliptin hydrobromide Teneligliptin is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor; competitively inhibited human plasma, rat plasma, and human recombinant DPP-...
T0178 Saxagliptin hydrate Saxagliptin is a selective and reversible DPP4 inhibitor (IC50: 26 nM; Ki: 1.3 nM).
T4042 Talabostat mesylate Talabostat mesylate is an orally active, selective inhibitor of dipeptidyl peptidases IV (DPP4, IC50: 0.18 nM), including tumor-associated fibroblast activation ...
T7369 Gemigliptin Gemigliptin is a potent dipeptidyl peptidase-4 (DPP-4) inhibitor(KD : 7.25 nM.)
T12710 Retagliptin Phosphate Retagliptin Phosphate is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes.
T7133 Anagliptin Anagliptin is a potent Inhibitor of DPP-4(IC50 of 3.8 nM), for the treatment of type 2 diabetes mellitus.
T15079 DBPR108 DBPR108 is an orally bioavailable dipeptide-derived DPP4 inhibitor (IC50: 15 nM) and it has no inhibition on DDP8 and DPP9.
T11248 Evogliptin tartrate Evogliptin tartrate has potential for anti-atherosclerosis therapy that targets arterial inflammation. Evogliptin tartrate is a potent, orally bioavailable and ...
T2296 Trelagliptin succinate Trelagliptin(SYR-472) is a long-acting inhibitor of dipeptidyl peptidase-4 (DPP-4), being developed for the treatment of type 2 diabetes (T2D).
Gemigliptin Tartrate(911637-19-9 free base)
T7369LCAS 1374639-74-3
Gemigliptin tartrate is a highly selective, reversible and competitive inhibitor of dipeptidyl peptidase-4 (DPP-4). It has an IC50 of 10.3 nM for human recombi...
Alogliptin Benzoate
T2401CAS 850649-62-6
Alogliptin Benzoate(SYR 322), an effective and specific DPP-4 inhibitor (IC50<10 nM), exhibits greater than 10, 000-fold selectivity over DPP-8/9. Alogliptin may...
Omarigliptin
T2316CAS 1226781-44-7
Omarigliptin has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Chronic Renal Insufficiency.
Vildagliptin
T1502CAS 274901-16-5
Vildagliptin is a cyanopyrrolidine-based, orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Vildagliptin's cyano moiet...
Saxagliptin
T6203CAS 361442-04-8
Saxagliptin is a selective and reversible DPP4 inhibitor with IC50 of 26 nM.
Picolamine
T1581CAS 3731-52-0
Picolamine acts as a potential inhibitor of DPP-4.
Sitagliptin
T0242CAS 486460-32-6
Sitagliptin, a new oral hypoglycemic (anti-diabetic drug), is a new dipeptidyl peptidase-4 (DPP-4) inhibitor. This enzyme-inhibiting drug is used either alone or...
3-Pyridylacetic acid hydrochloride
T1366CAS 6419-36-9
3-Pyridylacetic acid hydrochloride is an organic compund.
Linagliptin
T0191CAS 668270-12-0
Linagliptin is a potent, orally bioavailable dihydropurinedione-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity.
Alogliptin
T6192CAS 850649-61-5
Alogliptin(SYR-322) is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10, 000-fold selectivity over DPP-8 and DPP-9.
Trelagliptin
T6237CAS 865759-25-7
Trelagliptin is a highly specific and long-acting DPP-4 inhibitor.
Saikogenin A
T16838CAS 5092-09-1
Saikogenin A is a dipeptidyl peptidase-4 inhibitor.
Teneligliptin hydrobromide
T6999CAS 906093-29-6
Teneligliptin is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor; competitively inhibited human plasma, rat plasma, and human recombinant DPP-...
Saxagliptin hydrate
T0178CAS 945667-22-1
Saxagliptin is a selective and reversible DPP4 inhibitor (IC50: 26 nM; Ki: 1.3 nM).
Talabostat mesylate
T4042CAS 150080-09-4
Talabostat mesylate is an orally active, selective inhibitor of dipeptidyl peptidases IV (DPP4, IC50: 0.18 nM), including tumor-associated fibroblast activation ...
Gemigliptin
T7369CAS 911637-19-9
Gemigliptin is a potent dipeptidyl peptidase-4 (DPP-4) inhibitor(KD : 7.25 nM.)
Retagliptin Phosphate
T12710CAS 1256756-88-3
Retagliptin Phosphate is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes.
Anagliptin
T7133CAS 739366-20-2
Anagliptin is a potent Inhibitor of DPP-4(IC50 of 3.8 nM), for the treatment of type 2 diabetes mellitus.
DBPR108
T15079CAS 1186426-66-3
DBPR108 is an orally bioavailable dipeptide-derived DPP4 inhibitor (IC50: 15 nM) and it has no inhibition on DDP8 and DPP9.
Evogliptin tartrate
T11248CAS 1222102-51-3
Evogliptin tartrate has potential for anti-atherosclerosis therapy that targets arterial inflammation. Evogliptin tartrate is a potent, orally bioavailable and ...
Trelagliptin succinate
T2296CAS 1029877-94-8
Trelagliptin(SYR-472) is a long-acting inhibitor of dipeptidyl peptidase-4 (DPP-4), being developed for the treatment of type 2 diabetes (T2D).